12.07.2015 Views

Celiac Disease - NIH Consensus Development Program - National ...

Celiac Disease - NIH Consensus Development Program - National ...

Celiac Disease - NIH Consensus Development Program - National ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Epidemiology of <strong>Celiac</strong> <strong>Disease</strong>: What Are the Prevalence,Incidence, and Progression of <strong>Celiac</strong> <strong>Disease</strong>?Marian J. Rewers, M.D., Ph.D.Definition of <strong>Disease</strong><strong>Celiac</strong> disease (CD) is a chronic, systemic, autoimmune disorder induced by glutenproteins present in wheat, barley, and rye. Genetically susceptible persons develop autoimmuneinjury to the gut, skin, liver, joints, uterus, and other organs. The classical definition of CDincludes gastrointestinal manifestations confirmed by a small bowel biopsy (SBB) with findingsof villous atrophy, crypt hyperplasia, and normalization of the villous architecture in response togluten-free diet. (1,2) However, the clinical manifestation of CD has become more subtle andaffects mostly older children or adults. (3) SBB is poorly accepted by a majority of patients withmild or no symptoms, and the pathological examination of biopsy material is suboptimal in mostsettings. SBB is also hardly a “gold standard”—occasionally false-negative due to patchymucosal changes, often most severe in proximal jejunum, and typically not reached byendoscopic biopsy. This has led some to propose a new definition of CD, based on the presenceof serum IgA autoantibodies to tissue transglutaminase (IgA TG) and HLA-DQB1*0201 or*0302 alleles. (4) These markers are increasingly used in screening for CD, but their truesensitivity and specificity is debatable due to problems with some IgA TG assays andverification bias—overestimation of sensitivity and underestimation of specificity due to lack ofSBB studies in TG-negative screenees.PrevalencePrevalence of childhood CD has been reported to be as high as 1 in 77 among Swedish2 ½-year-olds, (5) 1 in 99 (using SBB as criterion) or 1 in 67 (using presence of IgA TG andHLA-DQB1*0201 or *0302) in Finnish schoolchildren, (4) and 1 in 230 in Italian school-agechildren. (6) In the United States, the frequency of CD among adults varies from 1 in 1,750 (withCD defined as clinical cases including dermatitis herpetiformis) (3) to 1 in 105 (CD defined bypresence of IgA TG in blood donors (7) ). The estimates based on sero-epidemiological studiessuggest that for each diagnosed case of CD, there may be 3–7 undiagnosed cases.IncidenceCumulative incidence of SBB-confirmed CD in children has been reported between 1 in285 in Sweden (8) and 1 in 588 in New Zealand. (9) In Colorado, the risk estimate for developingCD—defined as IgA TG positivity by the age of 5—was 1 in 104 (95 percent CI 1:49–221). (10)Population-based estimates of the incidence of SBB-confirmed CD in adults vary from2–13/100,000. (3,9) The recent increase in the incidence rates is likely due to increasing use ofserologic screening, leading to diagnosis in milder cases. Infant and early childhood nutritionvaries among populations. Differences in the prevalence of susceptibility HLA alleles mayexplain interpopulation variation in the incidence of CD. The effects of nutritional practices on45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!